East Coast Institute for Research

Jacksonville, Florida 32258

2 studies enrolling now · 31 studies all time

What they study most

Acute Coronary Syndrome, Angina Pectoris, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Cardiovascular Disease and Lipoprotein(a), Cataract, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Crohn's Disease, Diabetes, Diabetes Mellitus, Type 1, Diabetic Macular Edema

Studies at this site

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia — Recruiting now
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec — Completed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation — Completed
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients — Running, not enrolling
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) — Completed
Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) — Completed
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes — Completed
Avexitide for Treatment of Post-Bariatric Hypoglycemia — Running, not enrolling
OP5-005 Using Omnipod 5 in Adults With Type 2 — Completed
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure — Completed
InterStim Micro Post Market Clinical Follow-up Study (ELITE) — Stopped early
A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy — Completed
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD — Completed
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) — Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes — Completed
InterStim® Amplitude Study — Completed
A Study of LY900014 in Participants With Type 1 Diabetes — Completed
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes — Completed
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy — Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus — Completed
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data — Completed
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) — Completed
Phase III Acute Coronary Syndrome — Stopped early
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism — Completed
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed